Globe Newswire05.06.20
Venus Concept Inc., a global medical aesthetic technology leader, has expanded its executive team with the appointment of Chad A. Zaring to the newly-created role of chief commercial officer (CCO). Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career.
“We are very excited to have Chad join our executive leadership team in a newly created role of chief commercial officer,” said Dom Serafino, CEO of Venus Concept Inc. “Chad is an industry veteran with the requisite experience leading global commercial strategies for innovative medical device companies which makes him an ideal fit. As CCO, he is responsible for global sales of both devices and services, as well as leading the development of Venus Concept’s commercial strategy to introduce new, minimally invasive, robotic solutions for medical aesthetic procedures that are only treated with invasive surgical interventions today.”
Prior to joining the Venus Concept, Zaring served as CCO at Titan Medical Inc., a publicly traded medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery.
Prior to Titan Medical, Zaring was vice president of Robotics, Imaging and Navigation at Medtronic plc. Prior to Medtronic, he was part of the senior leadership team at Mazor Robotics, responsible for the initiation of a global distribution agreement which subsequently led to the acquisition by Medtronic. In his sales leadership roles at both companies, he developed capital sales strategies, established new sales channels and consistently exceeded sales goals.
Earlier in his career, from October 2004 to April 2015, Zaring held positions of increasing responsibility at Intuitive Surgical and was a member of the leadership team that executed early and mid-stage adoption of their robotic surgery system across multiple surgical disciplines. Zaring began his career at Merrill Lynch in 1999 as a financial sales consultant. He later held sales positions at Merck and Co. and at Ethicon Endo-Surgery, a Johnson & Johnson company. He earned a bachelor of arts degree in biology from Juniata College in Huntingdon, Pa.
“This role represents a great opportunity given Venus Concept’s strong product portfolio, disruptive business model, and unique approach to creating lasting customer relationships, combined with their focus on robotics and innovative technology. I’m eager to leverage these strengths to drive our commercial success,” said Zaring.
“We are very excited to have Chad join our executive leadership team in a newly created role of chief commercial officer,” said Dom Serafino, CEO of Venus Concept Inc. “Chad is an industry veteran with the requisite experience leading global commercial strategies for innovative medical device companies which makes him an ideal fit. As CCO, he is responsible for global sales of both devices and services, as well as leading the development of Venus Concept’s commercial strategy to introduce new, minimally invasive, robotic solutions for medical aesthetic procedures that are only treated with invasive surgical interventions today.”
Prior to joining the Venus Concept, Zaring served as CCO at Titan Medical Inc., a publicly traded medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery.
Prior to Titan Medical, Zaring was vice president of Robotics, Imaging and Navigation at Medtronic plc. Prior to Medtronic, he was part of the senior leadership team at Mazor Robotics, responsible for the initiation of a global distribution agreement which subsequently led to the acquisition by Medtronic. In his sales leadership roles at both companies, he developed capital sales strategies, established new sales channels and consistently exceeded sales goals.
Earlier in his career, from October 2004 to April 2015, Zaring held positions of increasing responsibility at Intuitive Surgical and was a member of the leadership team that executed early and mid-stage adoption of their robotic surgery system across multiple surgical disciplines. Zaring began his career at Merrill Lynch in 1999 as a financial sales consultant. He later held sales positions at Merck and Co. and at Ethicon Endo-Surgery, a Johnson & Johnson company. He earned a bachelor of arts degree in biology from Juniata College in Huntingdon, Pa.
“This role represents a great opportunity given Venus Concept’s strong product portfolio, disruptive business model, and unique approach to creating lasting customer relationships, combined with their focus on robotics and innovative technology. I’m eager to leverage these strengths to drive our commercial success,” said Zaring.